Cheryl Dreyfus

Title: Cheryl Dreyfus: Innovator in Reproductive Health

Introduction

Cheryl Dreyfus is a prominent inventor based in Short Hills, NJ (US). She has made significant contributions to the field of reproductive health through her innovative research and patents. With a total of 2 patents, her work focuses on the utilization of neurotrophins to enhance reproductive capacity in female subjects.

Latest Patents

Dreyfus's latest patents include methods and kits designed to manipulate and predict the reproductive capacity of females. Her research highlights the role of endogenous neurotrophins and the addition of exogenous neurotrophins, particularly BDNF, NT-4/5, and NGF. These neurotrophins increase the reproductive capacity of female patients by binding to receptors on oocytes and stimulating their maturation. Furthermore, the administration of antagonists can act as a contraceptive by preventing neurotrophins from binding to oocyte receptors. Additionally, neurotrophins may be utilized to stimulate the maturation of oocytes in vitro.

Career Highlights

Cheryl Dreyfus is affiliated with the University of Medicine and Dentistry of New Jersey, where she continues her research and development in reproductive health. Her work has garnered attention for its potential applications in fertility treatments and contraceptive methods.

Collaborations

Dreyfus has collaborated with notable colleagues, including David B Seifer and Robert Shelden, to advance her research and explore new avenues in reproductive health.

Conclusion

Cheryl Dreyfus stands out as an innovative inventor in the field of reproductive health, with her research paving the way for new methods to enhance female reproductive capacity. Her contributions are significant and continue to impact the scientific community.